Abstract: UNLABELLED Boid inclusion body disease (BIDB) is a fatal disease of boid snakes, the etiology of which has only recently been revealed following the identification of several novel arenaviruses in diseased snakes. BIBD-associated arenaviruses (BIBDAV) are genetically divergent from the classical Old and New World arenaviruses and also differ substantially from each other. Even though there is convincing evidence that BIBDAV are indeed the etiological agent of BIBD, the BIBDAV reservoir hosts-if any exist besides boid snakes themselves-are not yet known. In this report, we use University of Helsinki virus (UHV; a virus that we isolated from a Boa constrictor with BIBD) to show that BIBDAV can also replicate effectively in mammalian cells, including human cells, provided they are cultured at 30°C. The infection induces the formation of cytoplasmic inclusion bodies (IB), comprised mainly of viral nucleoprotein (NP), similar to those observed in BIBD and in boid cell cultures. Transferring infected cells from 30°C to 37°C ambient temperature resulted in progressive declines in IB formation and in the amounts of viral NP and RNA, suggesting that BIBDAV growth is limited at 37°C. These observations indirectly indicate that IB formation is linked to viral replication. In addition to mammalian and reptilian cells, UHV infected arthropod (tick) cells when grown at 30°C. Even though our findings suggest that BIBDAV have a high potential to cross the species barrier, their inefficient growth at mammalian body temperatures indicates that the reservoir hosts of BIBDAV are likely species with a lower body temperature, such as snakes. IMPORTANCE The newly discovered boid inclusion body disease-associated arenaviruses (BIBDAV) of reptiles have drastically altered the phylogeny of the family Arenavirus. Prior to their discovery, known arenaviruses were considered mainly rodent-borne viruses, with each arenavirus species having its own reservoir host. BIBDAV have so far been demonstrated in captive boid snakes, but their possible reservoir host(s) have not yet been identified. Here we show, using University of Helsinki virus as a model, that these viruses are able to infect mammalian (including human) and arthropod cells. Our results provide in vitro proof of the considerable ability of arenaviruses to cross species barriers. However, our data indicate that BIBDAV growth occurs at 30°C but is inhibited at 37°C, implying that crossing of the species barrier would be hindered by the body temperature of mammalian species. 
IMPORTANCE 21
The newly-discovered boid inclusion body disease-associated arenaviruses 22 (BIBDAV) of reptiles have drastically altered the phylogeny of the family Arenavirus. 23
Prior to their discovery, known arenaviruses were considered as mainly rodent-borne 24 viruses, with each arenavirus species having its own reservoir host. BIBDAV have so 25 far been demonstrated in captive boid snakes but their possible reservoir host(s) have 26 not yet been identified. Here we show, using University of Helsinki virus as a model, 27 that these viruses are able to infect mammalian (including human) and arthropod 28 cells. Our results provide in vitro proof of the considerable ability of arenaviruses to 29 cross species barrier. However, our data indicate BIBDAV growth occurs at 30˚C but 30 is inhibited at 37˚C, implying that crossing of the species barrier would be hindered 31 by the body temperature of mammalian species. 32
INTRODUCTION 34
Arenavirus is the genus in the family Arenaviridae, RNA viruses that have earlier 35 been described as almost exclusively rodent-borne (1) . Several arenaviruses are 36 known to be able to cross the species barrier, for instance to be transmitted from a 37 rodent host to humans (2-4). Such cross-species transmission often leads to severe 38 infections which manifest as hemorrhagic fever (Lassa, Guanarito, Junin, Lujo, 39
Machupo, Sabia or Whitewater Arroyo virus) or meningitis (lymphocytic 40 choriomeningitis virus, LCMV) in humans (1, 5, 6) . While these are usually dead-end 41 events for the virus, they can occasionally lead to prolonged transmission chains 42 between humans (7). More recently, several arenaviruses have been detected in 43 snakes with boid inclusion body disease (BIBD) (8- detached with a cell scraper and pelleted by centrifugation (500 x g, 5 min, RT). The 128 cell pellets were suspended in 1 ml of cell culture supernatant containing recombinant 129 baculoviruses, incubated for 1 h at room temperature (RT), and transferred into two 130 175 cm 2 bottles to which 25 ml growth medium were added. The cells were collected 131 between 5 and 7 dpi. 132
The recombinant proteins were purified from cells infected with recombinant 133 baculovirus as follows: the cell pellet was suspended in 3 ml lysis buffer 1 (50 mM 134
Tris, pH 7.5), and the cell suspension centrifuged (4,000 x g, 10 min, RT). The 135 resultant pellet (containing the insoluble recombinant protein) was suspended in 5 ml 136 lysis buffer 1 and centrifuged as above. The resultant pellet was suspended in 5 ml 137 lysis buffer 2 (50 mM Tris, 150 mM NaCl, 0.1% Triton X-100, pH 7.5) and 138 centrifuged (4,000 x g, 30 min, 4˚C); the procedure was repeated once. After washes 139 with lysis buffer 2 the resultant pellet was suspended in 2 ml lysis buffer 3 (50 mM 140
Tris, 500 mM NaCl, 1% Triton X-100, pH 7.5) and centrifuged (16,000 x g, 5 min, 141 RT). The washing was repeated once using 3 ml lysis buffer 3. The resultant pelletwas homogenized in 9 ml binding buffer (50 mM Tris, 500 mM NaCl, 6 M guanidine-143
HCl, pH 8.0) by passing several times through an 18G needle on a 5 ml syringe. One 144 ml of Ni-NTA agarose beads (Invitrogen) equilibrated in binding buffer was added to 145 the cell homogenate, followed by 1 h incubation at RT. The beads were washed 3 146 times with binding buffer (500 x g, 3 min, RT, centrifugations), and the recombinant 147 proteins were eluted by addition of 1 ml elution buffer (50 mM Tris, 500 mM NaCl, 6 148 M Guanidine-HCl, 500 mM Imidazole, pH 8.0) and centrifugation 500 x g, (3 min, 149 RT). The elution was repeated three times. Concentration and buffer exchange (to 35 150 mM HEPES, 135 mM NaCl, 1 M guanidine-HCL, pH 8.2) of the recombinant 151 proteins was done using a centrifugal filter device with 10 kDa cut-off (Millipore). 152
For SDS-PAGE analysis, guanidine was removed with ethanol (1 part protein solution 153 + 9 parts ethanol) precipitation (30 min at -70˚C, centrifugation at 16,000 x g for 10 154 min at 4˚C). 155
Antibodies. 156
Purified rNP-N and rNP-C were used to produce polyclonal antisera, similarly to 157 those described in (10), by BioGenes GmbH, but with initial injections of 150 μg, 70 158 μg boosters on days 7 and 14, 150 μg boosters on day 28, and 70 μg boosters on day 159 42. A previously prepared rabbit antiserum against purified and lysed UHV (10), and 160 the antisera produced against rNP-N and rNP-C were affinity purified by rNP coupled 161 to CnBr activated Sepharose (GE Healthcare) according to the manufacturer's 162 protocol. The affinity purified rNP-N and rNP-C polyclonal antibodies (PAb) were 163 labeled with horseradish peroxidase (HRP) using the EZ-Link Activated Peroxidase 164 Antibody Labeling Kit (ThermoScientific) as instructed by the manual. 165
SDS-PAGE and immunoblotting.
Protein separations by SDS-PAGE (8 to 12% gels) and wet blotting of proteins onto 167 nitrocellulose (Whatman) were done according to standard protocols. The protein 168 concentrations of cell lysates (in 50 mM Tris, 150 mM NaCl, 1% Triton X-100, pH 169 8.0, supplemented with EDTA-free protease inhibitor cocktail, Roche) were 170 determined using the BCA Protein Assay Kit (Pierce, Thermo Scientific), and 10 μg 171 of total protein was loaded for each lane. Sample preparation for SDS-PAGE and 172 immunoblotting as well as the probing and detection of immunoblots using the anti-173 rNP PAb (affinity purified from anti-UHV serum, used at 0.1 μg/ml concentration) 174 were as described (10). The HRP-labelled anti-rNP-N and anti-rNP-C PAb were used 175 at 0.25 μg/ml to 0.1 μg/ml concentrations diluted in blocking buffer (50 mM Tris, 150 176 mM NaCl, 0.05% Tween 20, pH 8.0) with 3% skimmed milk powder. The results 177
were recorded on X-ray film (Fuji Medical RX) utilizing in-house ECL reagents. 178
Quantitative PCR (qPCR). For TEM, cells were scraped from the flasks and pellets prepared as above, fixed in 216 1.5% glutaraldehyde buffered in 0.2 M cacodylic acid buffer, pH 7.3, for 12 h at 5°C, 217 and routinely embedded in epoxy resin. Semi-thin and thin sections were prepared as 218 previously described (10), and the latter were examined for the presence and 219 morphology of BIBD IB, using a Philips CM 100. 220
For IF, cells were grown and infected either on diagnostic 10-well slides, or in culture 221 vessels, detached by pipetting (tick cells) or by trypsinization (vertebrate cells), 222
washed with PBS, diluted in PBS and dried on slides. After fixation in acetone for 10 223 min, slides were incubated with the anti-NP and anti-NP-C antibodies diluted in PBS 224 (0.25 μg/ml to 0.5 μg/ml), followed by Alexa Fluor 488-labeled or Alexa Fluor 555-225 labeled goat anti-rabbit (both 1:1,500 dilution in PBS; Invitrogen) for visualization. 226
RESULTS 228
Expression and purification of recombinant UHV NP. 229
We recently characterized two rabbit antisera raised against UHV purified from cell 230 cultures of boid cells (10). Both antisera reacted also with proteins of boid cells which 231 prompted us to produce and purify protein specific antibodies. For this purpose, we 232 produced UHV NP (rNP, aa 1-582), the N-terminal portion of NP (rNP-N, aa 1-339), 233 and the C-terminal portion of NP (rNP-C aa 346-582) with a histidine-tag, using a 234 baculovirus expression system. Immobilized-metal affinity chromatography (IMAC) 235 under denaturing conditions served to purify the proteins, and SDS-PAGE and 236
immunoblotting with anti-his antibody for estimating the purity of the preparations 237 (Fig. 1 , top left and middle panel). While rNP and rNP-C each yielded a single 238 distinct band, rNP-N produced a triplet band of the approximate expected molecular 239 size. It is likely that the triplet band is the result of either secondary modifications 240 (e.g. phosphorylation) or N-terminally fragmented pieces of the desired product (his-241 tag is located in the C-terminus), since all bands of the triplet were recognized by the 242 anti-his antibody (Fig. 1, top middle panel) . 243
The rNP coupled to CnBr Sepharose was used to affinity purify anti-NP PAb from 244 antiserum produced against UHV (10), and NP specific PAbs from antisera produced 245 against rNP-N and rNP-C. The anti-NP reacted strongly with infected cell lysates and 246 rNP, and rNP-C elicited a much stronger immunoreaction than rNP-N (Fig. 1, top  247 right panel), indicating epitope predominance in the C-terminus of NP. The PAbs 248 purified from rNP-N and rNP-C antisera were further labelled with HRP to facilitate 249 the direct use in downstream assays. Both anti-rNP-N and anti-tNP-C were found to 250 react with NP from infected cells and with rNP (Fig. 1, lower panels) . Both anti-rNP-251 N weakly reacted with rNP-C and vice versa (Fig. 1, lower panels) , most probably 252 due to the presence of his-tag in both proteins. 253
UHV infects cells at 30˚C but growth is limited or hindered at 37˚C. 254
In our recent paper we demonstrated that UHV not only grows in boid cells, but can 255 also infect and be adapted to grow in Vero E6 cells (10). Initial attempts at infecting 256 the cells with UHV under standard culturing conditions (5% CO 2 , 37˚C) had been 257 unsuccessful, whereas maintenance under conditions similar to those applied to the 258 boid cells (10), i.e. at ambient temperatures between 27˚C and 30˚C, resulted in 259 accumulation of UHV antigens. We thus infected both boid kidney and Vero E6 cells 260 with UHV (both Vero E6-and boa cell-adapted UHV), incubated the cells at either 261 30˚C or 37˚C, and monitored the virus growth by immunoblotting to detect the 262 accumulation of NP. When grown at 30˚C, both cell lines express NP already 2 days 263 post infection (dpi), whereas no NP is detected in cells grown at 37˚C (Fig. 2) , 264 indicating that growth is inhibited or markedly hindered at the higher temperature. Table 1.  275 Regardless of the ambient temperature, boid kidney cells infected with boa-UHV 276 exhibited variably sized (0.5 -3.5 µm) IB in a moderate proportion (up to 40%) of 277 cells, whereas viral NP expression was obvious in more than 50% of the cells, with an 278 overall weak to moderate expression intensity (Fig.3A) . When consistently 279 maintained at 30°C Vero-UHV induced a more intense infection in the boid cells (up 280 to 80% NP-positive cells and moderate NP expression intensity; Fig. 3B ). In contrast, 281 incubation at 37°C reduced both the proportion of cells with IB and the degree of NP 282 expression. This was most pronounced in cells consistently maintained at 37°C, when 283 IB were often barely visible and only faint NP expression confirmed infection of the 284 cells ( Fig. 3C ; Table 1 ). The results show that both boa-and Vero-UHV can 285 productively infect boid cells. However, once the virus is adapted to Vero E6 cells, its 286 replication capacity appears to decline with an increase in ambient temperature. 287
At a consistent ambient temperature of 30°C, Vero-UHV yielded similar results in 288
Vero E6 cells as boa-UHV in boid kidney cells (up to 40% cells with IB of 0.5 -3.0 289 µm diameter, moderate NP expression in up to 40% of cells; Fig. 3D ). Boa-UHV 290 infected the Vero E6 cells at 30°C, but with low efficiency, since no more than 20% 291 of cells had developed IB at 8 dpi, and NP was only weakly expressed (Fig. 3E) . 292
Incubation at 37°C for any length of time resulted in an even lower efficiency of 293 infection (Table 1) . Interestingly, the infection with Vero-UHV seemed to fail when 294 the cells were incubated at 37°C immediately after infection (Table 1) . These findings 295 suggest that adaptation of UHV to Vero E6 cells is associated with loss of its capacity 296 to infect and grow in these cells at 37°C, perhaps through selection during adaptation. 297
The ultrastructural characteristics of the IB were very similar irrespective of the 298 infected cell line or the virus isolate used when cells were grown at 37°C (Fig 4) . The 299 kinetics of IB formation appeared to be similar in both cell lines. At 8 dpi, the 300 majority of IB were of irregular shape. By 12 dpi, they had acquired the round to 301 ovoid shape of the IB typically seen in cells of boids with BIBD (10). At this stage, 302 the number of IB overall appeared to be lower than at 8 dpi (data not shown). 303
Exposure of infected cells to higher ambient temperatures leads to a decrease in 304 the amount of NP. 305
Since growth of UHV was found to be impaired at 37˚C, we decided to more closely 306 investigate the effect of a temperature rise to 37˚C on cells infected and initially 307 grown at 30˚C. We therefore passaged UHV-infected cells at 15 dpi (boid cells) and 308 12 dpi (Vero E6 cells) and incubated the new plates at either 30˚C or 37˚C. UHV 309 replication was monitored at 2-day intervals by quantifying the amount of UHV NP in 310 cells using immunoblotting. The temperature increase to 37˚C was associated with a 311 gradual, time-dependent decrease in the amount of UHV NP in cells, indicating that 312 the higher temperature adversely affected the replication of UHV (Fig. 5A) . The 313 observed decrease in NP also indicates that the cells lose the accumulated NP deposits 314 likely through the normal cell turnover, since cytopathic effects were not seen. This 315 would suggest that the IB are indeed dynamic complexes, and essential for replication 316 (13). 317
To analyse whether the decrease in NP would be due to impaired replication of the 318 virus, we compared the amount of viral RNA (both genomic and anti-genomic) after 319 incubation at different temperatures. We infected boid cells with boa-UHV, incubated 320 them at 30˚C or 37˚C for 5 d, and then transferred a plate of cells grown at 30˚C to 321 37˚C, and vice versa. Cells maintained at 30˚C and 37˚C for the entire examination 322 period served as controls. Samples collected daily up to 8 dpi were analysed by qPCR 323 using UHV Z protein-specific primers which showed that UHV replication is 324 dramatically reduced at 37˚C (Fig. 5B) ; however, when such cells were transferred to30˚C after 5 d, replication restarted. When cells grown at 30˚C were transferred to 326 37˚C, the amount of viral RNA decreased; interestingly, the amount of viral RNA 327 started to increase again after 4 d at the higher temperature, after the initial decrease 328 but at levels approximately 20-40 times lower than in cells grown at 30˚C. Despite the 329 modest recovery of RNA levels (Fig 5B) , no protein expression was seen in cells 330 grown at 37˚C (Fig. 2) . 331 UHV originates from a chronically-infected boid bone marrow cell line passaged for 332 more than 10 years at temperatures between 27˚C and 30˚C (10). Therefore, in order 333 to exclude previous cell culture adaptation to a specific temperature range, we decided 334 to study the temperature preference of a recently isolated, genetically distant, 335 BIBDAV (T10404; from snake no. 5 in (10)). We infected both Vero E6 and boid 336 cells with T10404 and maintained the cultures at 30˚C or 37˚C; at 4 dpi we performed 337 temperature swaps and monitored virus growth in samples collected at 5, 7, and 9 dpi 338 as above. The progressive decline in the amount of NP indicates that also the 339 replication of T10404 is impaired in both cell types at 37˚C (Fig. 5C, lanes 2, 5 and 8 ) 340 in comparison to cells grown at 30˚C (Fig. 5C, lanes 1, 4 and 7) . Different from the 341 Vero E6 cells, boid cells inoculated with the virus at 37˚C started to produce virus 342 once transferred to 30˚C (Fig. 5C, lanes 3, 6 and 9) , suggesting that, similar to UHV, 343 T10404 retains its infectivity and/or replicates at a low level in boid cells at a higher 344 temperature. 345
UHV infects cells from different animal classes. 346
To further investigate the potential of BIBDAV to infect cells other than boid and 347 non-human primate cells (Vero E6), we infected a range of cell lines originating from 348 different animal classes (mammalian, arthropod) with UHV. We wanted to test 349 replication of BIBDAV in arthropod cells, since BIBD epidemics are oftenconcomitant with snake mite infestation (25), and snake mites could act as a vector 351 for BIBDAV. Since mite cells are not available, we used tick cell lines instead. We 352 found evidence of UHV growth (NP production) by both IF (Fig. 6A) and in the case of boids and other snakes known to develop BIBD these are often 385 higher. Our findings thus suggest that in wild snakes the replication of BIBDAV 386 could be restricted or influenced by changes in the ambient temperature, and that the 387 susceptibility of a snake species might actually be related to the environment in which 388 it lives. Chronic infection of the reservoir host is seen with "classical" rodent-borne 389 arenaviruses, and is considered almost a hallmark of the family Arenaviridae. 390 Accordingly, BIBDAV could chronically infect boids living in the wild, however, to 391 our knowledge there is so far no report suggesting this. The fact that UHV was able to infect such a broad range of cell lines, and that UHV 410 was still able to infect boid cells after it was adapted to Vero E6 cells through 411 cultivation, is particularly interesting with regards to its potential receptor usage. Boid and Vero E6 cells infected with UHV (15 dpi and 12 dpi, respectively) were 597 transferred to fresh 6-well plates and grown at 30˚C or 37˚C. Cells were collected at 598 two day interval in lysis buffer and 10 μg of total protein from each time point was 599
analysed by immunoblotting using HRP-labelled anti-rNP-C antibody. The results 600 were recorded on X-ray film utilizing ECL. B) Boid cells were infected with UHV 601 and grown at 30˚C or 37˚C. At 5 dpi a plate of cells grown at 37˚C was transferred to 602 30˚C and a plate of cells grown at 30˚C to 37˚C. Infected cells constantly kept at 30˚C 603 or 37˚C were used as controls. RNA isolated from cells collected at 5, 6, 7, and 8 dpi 604 (x-axis) was quantified with qPCR using UHV Z protein-specific primers. The results 605 are shown as fold increase in comparison to the vRNA level of cells grown at 37˚C (2 606 dpi, the highest Ct value measured). C) Boid and Vero E6 cells were infected with 607 The effect of ambient temperature on the growth of UHV and T10404. A) Boid and Vero E6 cells infected with UHV (15 dpi and 12 dpi, respectively) were transferred to fresh 6-well plates and grown at 30˚C or 37˚C. Cells were collected at two day interval in lysis buffer and 10 mg of total protein from each time point was analysed by immunoblotting using HRP-labelled anti-rNP-C antibody. The results were recorded on X-ray film utilizing ECL. B) Boid cells were infected with UHV and grown at 30˚C or 37˚C. At 5 dpi a plate of cells grown at 37˚C was transferred to 30˚C and a plate of cells grown at 30˚C to 37˚C. Infected cells constantly kept at 30˚C or 37˚C were used as controls. RNA isolated from cells collected at 5, 6, 7, and 8 dpi (x-axis) was quantified with qPCR using UHV Z protein-specific primers. The results are shown as fold increase in comparison to the vRNA level of cells grown at 37˚C (2 dpi, the highest Ct value measured). C) Boid and Vero E6 cells were infected with T10404 and cultured at 30˚C or 37˚C. At 4 dpi the cells grown at 37˚C were transferred to 30˚C (37˚C=>30˚C), and a plate of cells grown at 30˚C was transferred to 37˚C (30 ˚C=>37˚C). Infected cells kept constantly at 30˚C were used as positive controls. Cells were collected in lysis buffer and 10 mg of t o ta l pr o te i n f r om ea ch ti m e p oi n t w a s a n al y se d by immunoblotting using affinity purified anti-UHV NP antibody (anti-rNP-N and anti-rNP-C yielded lower signal intensity). The immunoblot was recorded using Odyssey Infrared Imaging System (LI-COR). 
